Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2021-04-07 Report Publication Anno…
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2021
Report Publication Announcement Classification · 99% confidence The document is titled 'Correction: Blue Vision A/S - Årsrapport 2020' and explicitly states it is a 'KORREKTION - Justeret årsrapport for 2020' (Correction - Adjusted Annual Report for 2020). Although it refers to an Annual Report ('Årsrapport'), the document itself is very short (810 chars) and its primary function is to announce the correction and provide a link to the attached, corrected report. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement pointing to the main report should be classified as a Report Publication Announcement (RPA). The content is an announcement about the publication/re-publication of a key report.
2021-04-07 Danish
Audit Report / Information 2020
Audit Report / Information Classification · 98% confidence The document is explicitly titled "Årsrapport 2020" (Annual Report 2020) and contains a full table of contents listing sections typical of a comprehensive annual filing, such as 'Ledelsesberetning' (Management Report), 'Resultatopgørelse' (Income Statement), 'Balance' (Balance Sheet), and 'Pengestrømsopgørelse' (Cash Flow Statement). Crucially, it includes 'Den uafhængige revisors revisionspåtegning' (The independent auditor's report), which confirms the document is the full annual financial statement package. Although the document is Danish, the structure aligns perfectly with a comprehensive annual report, which corresponds to the 10-K category in US filings, or a general Annual Report (AR) if 10-K is strictly reserved for SEC filings. Given the comprehensive nature (including full financial statements and audit opinion), it is best classified as an Annual Report (AR), as 10-K is typically reserved for US SEC filings, and AR covers standalone audit reports or comprehensive annual reports outside of the 10-K context. Since this is the full annual report, AR is the most appropriate fit among the provided options for a comprehensive yearly report. FY 2020
2021-03-31 English
Report Publication Announcement 2021
Report Publication Announcement Classification · 99% confidence The document is explicitly titled 'Blue Vision A/S - Årsrapport 2020' (Annual Report 2020) and contains detailed financial summaries for the year 2020, including net result, equity, solvency ratio, and management discussion regarding significant losses and future strategy. Although it is short and mentions an attached file, the content provided is a substantial summary and discussion of the full annual results, which aligns closely with the content expected in an Annual Report (10-K equivalent for non-US entities, or a comprehensive annual filing). However, given the presence of the explicit attachment link and the structure resembling a press release announcing the finalization of the report, we must apply the 'MENU VS MEAL' rule. The document states the board 'has processed and approved the Company's annual report for 2020' and then provides key highlights and management commentary, concluding with an attachment link. This structure strongly suggests it is an announcement about the publication of the full report rather than the full report itself. Since it is an announcement regarding the publication of a major report, the most appropriate classification is Report Publication Announcement (RPA). If the text were much longer and contained the full audited statements, 10-K would be appropriate, but here it functions as the release notice.
2021-03-31 Danish
Capital/Financing Update 2021
Capital/Financing Update Classification · 95% confidence The document is a short announcement (2328 characters) from Blue Vision A/S, dated March 10, 2021, titled 'orientering om tilgodehavende' (orientation/update on receivable). It discusses an extension of a payment deadline, the impact of COVID-19, and new terms agreed upon regarding a debtor's payment schedule and interest rate. This type of communication, detailing specific financial arrangements, debt restructuring, or material updates outside of standard periodic reports (like 10-K or IR), often falls under general regulatory announcements or specific financial updates. Since it is not a full report (like 10-K or IR), nor a dividend notice (DIV), management discussion (MDA), or earnings release (ER), and it details a specific financial/legal arrangement (debtor extension), it best fits the 'Regulatory Filings' (RNS) category as a general, material, non-standard announcement, or potentially 'Capital/Financing Update' (CAP) due to the debt restructuring. Given the nature of updating stakeholders on a specific receivable/debtor situation, RNS is the most appropriate general regulatory fallback for this specific type of material update that doesn't fit the other specific financial codes.
2021-03-10 Danish
Legal Proceedings Report 2021
Legal Proceedings Report Classification · 99% confidence The document is a company announcement (Selskabsmeddelelse nr. 4) from Blue Vision A/S dated March 5, 2021. The content explicitly details the company concretizing a compensation claim (erstatningskrav) against former owners and executives related to the acquisition of Heartcare ApS. This involves legal action, assessment of losses, and references to previous financial provisions (half-year report, Dec 31, 2020 announcement). Since the document is an update on a significant legal/regulatory matter involving potential liabilities and is not a full financial report (like 10-K or IR), nor is it a general regulatory filing (RNS), the most appropriate category is Legal Proceedings Report (LTR), as it concerns significant lawsuits and legal matters.
2021-03-05 Danish
Share Issue/Capital Change 2021
Share Issue/Capital Change Classification · 99% confidence The document is a short official announcement (827 characters) from Blue Vision A/S, dated March 2, 2021, titled 'Blue Vision A/S – kapitalnedsættelse gennemført' (capital reduction completed). It explicitly states that a previously decided capital reduction has been finalized and details the resulting new share capital structure (DKK 15,909,227). This action directly relates to changes in the company's capital structure, specifically a reduction. Based on the definitions, 'Capital/Financing Update' (CAP) is the most appropriate category for formal announcements regarding capital structure changes, such as a completed capital reduction.
2021-03-02 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.